Definitions

from Wiktionary, Creative Commons Attribution/Share-Alike License.

  • noun A particular drug used in chemotherapy.

Etymologies

Sorry, no etymologies found.

Support

Help support Wordnik (and make this page ad-free) by adopting the word ixabepilone.

Examples

  • The drug, also known by its generic name ixabepilone, falls into a new class of drugs known as epothilones.

    Bristol-Myers Cancer Drug 2007

  • The U.S. Food and Drug Administration has approved Ixempra (ixabepilone), a new anti-cancer treatmen ...

    THE MEDICAL NEWS Editors 2010

  • The combination of Ixempra® (ixabepilone) and Xeloda® (capeciteabine) significantly increases progression-free survival in women with triple-negative metastatic breast cancer, according to the results of a study presented at the San Antonio Breast Cancer Symposium on December 12, 2008.

    unknown title 2009

  • The combination of Ixempra® (ixabepilone) and Xeloda® (capeciteabine) significantly increases progression-free survival in women with triple-negative metastatic breast cancer, according to the results of a study presented at the San Antonio Breast Cancer Symposium on December 12, 2008.

    unknown title 2009

  • The combination of Ixempra® (ixabepilone) and Xeloda® (capeciteabine) significantly increases progression-free survival in women with triple-negative metastatic breast cancer, according to the results of a study presented at the San Antonio Breast Cancer Symposium on December 12, 2008.

    unknown title 2009

  • The combination of Ixempra® (ixabepilone) and Xeloda® (capeciteabine) significantly increases progression-free survival in women with triple-negative metastatic breast cancer, according to the results of a study presented at the San Antonio Breast Cancer Symposium on December 12, 2008.

    unknown title 2009

  • The combination of Ixempra® (ixabepilone) and Xeloda® (capeciteabine) significantly increases progression-free survival in women with triple-negative metastatic breast cancer, according to the results of a study presented at the San Antonio Breast Cancer Symposium on December 12, 2008.

    unknown title 2009

  • The combination of Ixempra® (ixabepilone) and Xeloda® (capeciteabine) significantly increases progression-free survival in women with triple-negative metastatic breast cancer, according to the results of a study presented at the San Antonio Breast Cancer Symposium on December 12, 2008.

    unknown title 2009

  • -- two cancer drugs: the internally developed and recently approved Ixempra (ixabepilone), a new cytotoxic designed to overcome drug resistance; and ipilimumab (MDX-010), a potential new immunotherapy paradigm;

    Bristol-Myers Press Release 2007

Comments

Log in or sign up to get involved in the conversation. It's quick and easy.